SHBI Stock Analysis: Shore Bancshares | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 770m USD | 12M Return: 40.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.23M
EPS Trend: 78.6%
Qual. Beats: 1
Rev. Trend: 85.2%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Shore Bancshares, Inc. (NASDAQ: SHBI) is a bank holding company that operates Shore United Bank, N.A., headquartered in Easton, Maryland, and founded in 1876. The company provides a full suite of consumer and commercial banking products and services, including deposit products such as checking, savings, money market, and IRA certificates of deposit, as well as commercial loans, residential mortgage and construction loans, and consumer lending products like home equity, auto, and personal lines of credit. Beyond core banking, Shore Bancshares offers trust and wealth management services, treasury management solutions, merchant card processing, remote deposit capture, ACH origination, and digital banking channels, serving individuals, businesses, and other organizations in the United States.
As a small-cap regional bank within the Financials sector, Shore Bancshares operates a traditional community banking model in which net interest income (the difference between interest earned on loans and interest paid on deposits) is typically the primary revenue driver. Regional banks of this size generally depend on local deposit gathering and relationship-based lending, with wealth management and treasury services providing non-interest income to diversify the revenue mix.
- Net interest margin compresses as Fed cuts rates
- Commercial real estate loan losses pressure earnings
- Deposit growth and loan demand expand across Mid-Atlantic markets
| Net Income: 62.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.17 > 1.0 |
| NWC/Revenue: 15.55% < 20% (prev -1.47k%; Δ 1.48k% < -1%) |
| CFO/TA 0.01 > 3% & CFO 74.2m > Net Income 62.8m |
| Net Debt (66.2m) to EBITDA (97.9m): 0.68 < 3 |
| Current Ratio: 5.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (33.4m) vs 12m ago 0.22% < -2% |
| Gross Margin: 64.99% > 18% (prev 60.77%; Δ 4.22% > 0.5%) |
| Asset Turnover: 5.58% > 50% (prev 5.37%; Δ 0.20% > 0%) |
| Interest Coverage Ratio: 0.73 > 6 (EBIT TTM 83.1m / Interest Expense TTM 113.5m) |
| A: 0.01 (Total Current Assets 64.7m - Total Current Liabilities 11.0m) / Total Assets 6.21b |
| B: 0.04 (Retained Earnings 246.6m / Total Assets 6.21b) |
| C: 0.01 (EBIT TTM 83.1m / Avg Total Assets 6.19b) |
| D: 0.11 (Book Value of Equity 602.7m / Total Liabilities 5.60b) |
| Altman-Z'' = 0.39 = B |
| DSRI: 0.97 (Receivables 20.7m/20.6m, Revenue 345.3m/331.8m) |
| GMI: 0.94 (GM 60.77% / 64.99%) |
| AQI: 1.10 (AQ_t 0.98 / AQ_t-1 0.89) |
| SGI: 1.04 (Revenue 345.3m / 331.8m) |
| TATA: -0.00 (NI 62.8m - CFO 74.2m) / TA 6.21b) |
| Beneish M = -3.03 (Cap -4..+1) = AA |
As of July 08, 2026, the stock is trading at USD 22.60 with a total of 166,890 shares traded. Over the past week, the price has changed by -1.82%, over one month by +5.71%, over three months by +18.50% and over the past year by +40.58%.
Current recommended Stop Loss: 21.90 (which is 3.1% or 1.2 ATR below the current price).
Shore Bancshares has received a consensus analysts rating of 3.67. Therefore, it is recommended to hold SHBI.
- StrongBuy: 0
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 22.3 | -1.5% |
P/E Trailing = 12.25
P/E Forward = 9.7752
P/S = 3.4336
P/B = 1.2784
P/EG = 1.1676
Revenue TTM = 345.3m USD
EBIT TTM = 83.1m USD
EBITDA TTM = 97.9m USD
Long Term Debt = 89.0m USD (from longTermDebt, last quarter)
Short Term Debt = 1.51m USD (from shortTermDebt, last quarter)
Debt = 110.2m USD (from shortLongTermDebtTotal, last quarter) + Leases 10.6m
Net Debt = 66.2m USD (calculated: Debt 110.2m - CCE 44.1m)
Enterprise Value = 836.7m USD (770.5m + Debt 110.2m - CCE 44.1m)
Interest Coverage Ratio = 0.73 (Ebit TTM 83.1m / Interest Expense TTM 113.5m)
EV/FCF = 11.79x (Enterprise Value 836.7m / FCF TTM 71.0m)
FCF Yield = 8.48% (FCF TTM 71.0m / Enterprise Value 836.7m)
FCF Margin = 20.55% (FCF TTM 71.0m / Revenue TTM 345.3m)
Net Margin = 18.20% (Net Income TTM 62.8m / Revenue TTM 345.3m)
Gross Margin = 64.99% ((Revenue TTM 345.3m - Cost of Revenue TTM 120.9m) / Revenue TTM)
Gross Margin QoQ = 69.73% (prev 63.36%)
Tobins Q-Ratio = 0.13 (Enterprise Value 836.7m / Total Assets 6.21b)
Interest Expense / Debt = 102.9% (Interest Expense 113.5m / Debt 110.2m)
Taxrate = 24.35% (20.2m / 83.1m)
NOPAT = 62.8m (EBIT 83.1m * (1 - 24.35%))
Current Ratio = 5.87 (Total Current Assets 64.7m / Total Current Liabilities 11.0m)
Debt / Equity = 0.18 (Debt 110.2m / totalStockholderEquity, last quarter 602.7m)
Debt / EBITDA = 0.68 (Net Debt 66.2m / EBITDA 97.9m)
Debt / FCF = 0.93 (Net Debt 66.2m / FCF TTM 71.0m)
Total Stockholder Equity = 583.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.01% (Net Income 62.8m / Total Assets 6.21b)
RoE = 10.76% (Net Income TTM 62.8m / Total Stockholder Equity 583.7m)
RoCE = 12.35% (EBIT 83.1m / Capital Employed (Equity 583.7m + L.T.Debt 89.0m))
RoIC = 1.02% (NOPAT 62.8m / Invested Capital 6.19b)
WACC = 7.84% (E(770.5m)/V(880.7m) * Re(8.96%) + (debt cost/tax rate unavailable))
Discount Rate = 8.96% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 91.11 | Cagr: 0.17%
[DCF] Terminal Value 77.97% ; FCFF base≈66.5m ; Y1≈76.2m ; Y5≈112.2m
[DCF] Fair Price = 48.48 (EV 1.69b - Net Debt 66.2m = Equity 1.62b / Shares 33.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 78.56 | EPS CAGR: 25.31% | SUE: 1.38 | # QB: 1
Revenue Correlation: 85.20 | Revenue CAGR: 27.35% | SUE: 0.68 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.50 | Chg30d=+0.00% | Revisions=+57% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.53 | Chg30d=+0.32% | Revisions=+57% | Analysts=3
EPS current Year (2026-12-31): EPS=2.08 | Chg30d=+0.24% | Revisions=+57% | GrowthEPS=+17.0% | GrowthRev=+8.2%
EPS next Year (2027-12-31): EPS=2.23 | Chg30d=+0.68% | Revisions=+25% | GrowthEPS=+6.8% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: +81% (up=13, down=0)